C5-anilinoquinazoline compounds and their use in treating cancer
US10273227B2 · kind B2 · utility
6Cited by
1References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2018 |
| Grant date | Apr 30, 2019 |
| Priority date | — |
| Expiry date | Apr 26, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2121/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention concerns compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 have any of the meanings hereinbefore defined in the description; process for their preparation; pharmaceutical compositions containing them and their use in treating KIT mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.